QT Vascular revises deal with Cordis to sell its product in US
DeeperDive is a beta AI feature. Refer to full articles for the facts.
MEDICAL supplies group QT Vascular said on Friday it has signed an amendment to its distribution agreement with Cordis Corporation.
The revised deal allows QT Vascular to sell its Chocolate PTA balloon catheter to a select group of 88 healthcare providers in the United States with immediate effect.
Before this amendment, Cordis was the sole distributor of the balloon catheter in the US. This change supports the group's goal of increasing the adoption and use of Chocolate PTA in the US.
"The group expects the distribution relationship with Cordis to continue to be collaborative and productive," it said.
It shares closed 0.2 cent lower at S$0.093 on the stock market on Friday.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?